Showing results (2471-2480 of 2,558) with videos related to
Sort By:
Pageof 256
Ebiomedicine|August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver diseaseMayada Metwally, Ali Bayoumi, Anis Khan, et al.Gastroenterology|May 8, 2018
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort StudyEduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.The Lancet. Oncology|October 17, 2016
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseJan Franko, Qian Shi, Jeffrey P Meyers, et al.Scientific Reports|August 10, 2019
Brain-behaviour modes of covariation in healthy and clinically depressed young peopleAgoston Mihalik, Fabio S Ferreira, Maria J Rosa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2021
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N TrialRichard A Adams, David J Fisher, Janet Graham, et al.Preventive Medicine|October 27, 2019
Associations of built environment and proximity of food outlets with weight status: Analysis from 14 cities in 10 countriesThomas Cochrane, Yan Yu, Rachel Davey, et al.Angewandte Chemie (International Ed. in English)|January 6, 2015
Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbALuke A Adams, Pooja Sharma, Biswaranjan Mohanty, et al.Lancet (London, England)|June 7, 2011
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialTimothy S Maughan, Richard A Adams, Christopher G Smith, et al.Nature Communications|September 7, 2021
The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signalingChen Shen, Anmada Nayak, Leif R Neitzel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2021
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active MonitoringJenny F Seligmann, David J Fisher, Louise C Brown, et al.Pageof 256